What the label says is common
The label is more useful than vague internet lists because it shows scale. In adult Wegovy trials, nausea, diarrhea, vomiting, constipation, and abdominal pain were all reported commonly, and the label says gastrointestinal reactions were reported most often during dosage escalation.
That does not mean those symptoms should be ignored forever. It means a good overview should tell readers that common side effects exist, then help them recognize when the pattern has become too severe, too prolonged, or too disruptive to dismiss.
References For This Section
When the reaction needs faster attention
MedlinePlus and the labels are the right place to get more serious warning language. Ongoing severe stomach pain, repeated vomiting, inability to keep fluids down, symptoms of dehydration, or sudden vision changes are not the same as mild, early nausea.
This is the line many bad funnel sites blur. A trustworthy page should explain that some reactions are expected, but also make it easy to recognize when the symptoms are severe enough that medical care comes before any eligibility form.
References For This Section
What to track before a review
Before asking for a review, write down the medication, when you started, how the dose changed, when the symptoms began, whether you saw a doctor, and whether you stopped the medication. That makes both the medical and claim-review conversation much sharper.
If the problem is mainly GI, go deeper on the gastroparesis page. If it is mainly vision, use the retinopathy page. If you want to understand the screening flow, the process page explains what information is usually requested first.
References For This Section